Research progress of HMGB1 gene polymorphism related to disease
10.3760/cma.j.issn.1673-4181.2019.04.015
- VernacularTitle:与疾病相关的HMGB1基因多态性研究进展
- Author:
Jingjiao ZHANG
1
;
Chunqing DENG
Author Information
1. 山西医科大学第一医院感染病科
- Keywords:
HMGB1 protein;
HMGB1 gene;
Single nucleotide polymorphisms;
Sepsis;
Malignant tumor
- From:
International Journal of Biomedical Engineering
2019;42(4):357-361
- CountryChina
- Language:Chinese
-
Abstract:
High mobility group protein B1 (HMGB1) is encoded by HMGB1 gene and is a highly conserved non-histone chromosomal binding protein widely present in the nucleus. It plays an important role in DNA replication and repair of eukaryotic cells. As a delayed inflammatory mediator, HMGB1 secreted or released extracellularly mediates inflammatory response in sepsis, autoimmune diseases, malignant tumors, liver-related diseases, and so on. In recent years, the studies of HMGB1 gene polymorphism have provided a theoretical basis for further clarifying the pathogenesis of diseases. These studies provided early predictions of disease susceptibility for early intervention and provided the basis for precise prevention and treatment of diseases. In this paper, the correlation between HMGB1 and clinical disease susceptibility and prognosis was reviewed.
